MedTrace Logo

HPV Prevalence in 16-20 Year Old Males

NCT04297670 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 681

Last updated 2020-03-05

No results posted yet for this study

Summary

In Quebec, 18 birth cohorts of girls were vaccinated against HPV (aged 9 to 29 years in 2020). With an observed vaccination coverage of \>80% an important herd effect might be expected. This study aim is to measure the HPV types prevalence in unvaccinated sexually active boys aged 16 to 20 years.

Conditions

Interventions

OTHER

Measurement of HPV types prevalence

Self collected genital samples to be tested for the presence of different HPV types.

Sponsors & Collaborators

  • Laval University

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
20 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04297670 on ClinicalTrials.gov